Skip to main content (Press Enter)
-

12. Intangible assets

Intangible Assets 2020

EUR 1,000
  Product development costs Other intangible assets Total
Acquisition cost 1 Jan   17,353 6,122 23,475
Exchange differences     -560 -560
Additions   3,403   3,403
Disposals     2 2
Acquisition cost 31 Dec   20,756 5,564 26,320
       
Accumulated amortisations and impairment losses 1 Jan   -14,406 -5,531 -19,937
Exchange differences     12 12
Amortisation during period   -1,036 -26 -1,062
Accumulated amortisations and impairment losses 31 Dec   -15,442 -5,545 -20,987
         
Book value 31 Dec 2020   5,314 19 5,333
 
Product development costs and impairment testing
Capitalized product development costs inlude EUR 3,449 (2,947) thousand such products that are not yet in commercial use, and therefore not amortized. These intangibles in progress are tested for impairment annually, and they are allocated to operating segments as follows: MEA & APAC EUR 2,771 (2,071) thousand and Americas & Europe EUR 729 (876) thousand. Based on the impairment tests performed, there is no need to recognize an impairment loss on intangibles in progress. Research and development costs recorded in the income statement are presented in note 8.
 
Intangible Assets 2019

EUR 1,000
  Product development costs Other intangible assets Total
Acquisition cost 1 Jan   14,406 6,952 38,886
Exchange differences     -75 -75
Additions   2,947   2,947
Disposals     -755 -755
Acquisition cost 31 Dec   17,353 6,122 41,003
       
Accumulated amortisations and impairment losses 1 Jan   -14,406 -6,753 -38,687
Exchange differences     849 849
Amortisation during period     -168 -168
Accumulated amortisations and impairment losses 31 Dec   -14,406 -6,072 -38,006
         
Book value 31 Dec 2019   2,947 50 2,997